Replies to post #217802 on Cytodyn Inc (CYDY)

[theswordman]

This is why Simes was brought in--to oversee the CYDY R/S for funding. There are not many options--none are good. This is a result of several years wasted allowing the khazempour nonsense/fraud

Here is link to SEC doc--biosante/Simes
https://www.sec.gov/Archives/edgar/data/1023024/000114420413044160/v349735_ex3-1.htm
_________________________________________________________________________
Here is link to He also negotiated the merger of RestorGenex with Diffusion Pharmaceuticals-- https://www.globenewswire.com/news-release/2014/03/07/616782/30316/en/Stratus-Media-Group-Announces-Name-Change-to-RestorGenex-and-Reverse-Split.html

Here is restorgenx with diffusion--Merger with Diffusion Pharmaceuticals LLC
As the Merger was not completed until January 8, 2016, the following discussion of executive compensation relates to our pre-Merger named executive officers during the year ended December 31, 2015, Stephen M. Simes, Philip B. Donenberg and Mark A. Weinberg, M.D., and the decisions and considerations of the RestorGenex Compensation Committee.

And--On March 5 2014, the Company entered into an Employment Agreement with Stephen M. Simes (the “Simes Employment Agreement”) pursuant to which Mr. Simes was appointed Chief Executive Officer of the Company. The Simes Employment Agreement is for an initial term of three years, subject to extension as provided therein. Mr. Simes is to receive a base salary at an annual rate of $425,000 with at least annual review and base salary increases as approved by the Board of Director or its Compensation Committee. He will have the opportunity to earn a bonus with respect to each year during his employment based upon achievement of performance objectives set by the Board or the Compensation Committee after consultation with Mr. Simes with a target bonus opportunity of 60% of base salary for each year. He will also receive an initial grant of options to purchase 50,000,000 pre-reverse stock split at a pre-reverse split exercise price of $0.02 per share which will vest quarterly over the initial three-year term of his employment.
________________________________________________________________________

There is 1 more company he asst with R/S but "maybe" you can find it on your own??--try your own DD--So yes--3 out of 3--to me that is a R/S expert